Evidence map›Paper›PMID 41050466›Full record

ArticleComputational and structural biotechnology journal2025

Machine learning and gene network integration reveal prognostic subnetworks and biomarkers in pancreatic cancer.

Rana Salihoglu, Jesus Nieves, Gudrun Dandekar, Regina Ebert, Maximilian Rudert, Thomas Dandekar, Elena Bencurova

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. An Interpretable Omics-to-Image Transformer Framework for Cancer Prognosis Prediction.Computational and structural biotechnology journal · 2026
    Article
  2. Article
  3. MUC13-Associated Molecular Interactome in Pancreatic Cancer.Computational and structural biotechnology journal · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rana SalihogluDepartment of Bioinformatics, University of Würzburg, Würzburg, Germany.
Jesus NievesDepartment for Functional Materials in Medicine and Dentistry, University Hospital Würzburg, Würzburg, Germany.
Gudrun DandekarDepartment for Functional Materials in Medicine and Dentistry, University Hospital Würzburg, Würzburg, Germany.
Regina EbertDepartment of Musculoskeletal Tissue Regeneration, Orthopedic Hospital König-Ludwig-Haus, University of Würzburg, Würzburg, Germany.
Maximilian RudertDepartment of Orthopedics, Orthopedic Hospital König-Ludwig-Haus, University of Würzburg, Würzburg, Germany.
Thomas DandekarDepartment of Bioinformatics, University of Würzburg, Würzburg, Germany.
Elena BencurovaDepartment of Bioinformatics, University of Würzburg, Würzburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pancreatic cancer has a high mortality rate and lacks early detection markers. Advanced methods, such as machine learning (ML) and network analysis, identify central cancer networks with potential diagnostic and prognostic biomarkers, leading to improved tumor targeting strategies Methods: We systematically collected pancreatic cancer transcriptome datasets from the databases TCGA, GTEx, and GEO. Weighted gene co-expression network analysis (WGCNA) identified gene modules associated with clinical traits. Multiple machine learning-based feature selection methods (Random Forest, Support Vector Machine, LASSO, ReliefF) and differential gene expression (DGE) analysis prioritized candidate genes. Functional enrichment (Gene Ontology and KEGG pathway database) examined biological processes involved in tumor progression and immune evasion. Survival analyses evaluated prognostic significance. Results: WGCNA identified pancreatic cancer networks from key gene modules strongly associated with cancer stage and survival. Common biomarkers, including transcripts from genes Conclusion: This study identified novel regulatory cancer networks and associated biomarkers for pancreatic cancer prognosis and diagnosis by integrating WGCNA with ML, DGE, pathway, and survival analyses. An interactive web portal to explore the full results and visualizations is available at pc-biomarkers.de. Future work will further validate these biomarkers to improve early detection, prognosis, and treatment strategies.

Indexed as

biomarkerfeature selectionmachine learningPancreatic cancerWGCNA

Identifiers

PMID41050466
PMCPMC12495057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.